|Last Price$85.34||Day Change (%)0.36%|
|Open Price$84.85||Day Change ($)0.31|
|Day Range84.56–86.05||52-Week Range57.14–96.58|
As of Fri 5/22/2015 11:54:00 AM | USD
UPDATE: Etsy shares fall after results show surprise loss
First Ever Peyronie's Disease (PD) Treatment Guidelines Support Use of XIAFLEX® in Appropriate Patients
MARKET SNAPSHOT: S&P 500, Dow Close At All-time Highs
UPDATE: S&P 500, Dow close at all-time highs
Endo Announces Updated XIAFLEX® Label with Recurrence and Retreatment Data in Patients with Dupuytren's Contracture
Endo Acquires Broad Portfolio of Branded and Generic Products, Expanding International Pharmaceuticals Business
Endo Pharmaceuticals and BioDelivery Sciences Present Pivotal Data from Two Phase 3 Trials Demonstrating Safety and Efficacy of Buprenorphine HCl Buccal Film for the Management of Chronic Pain
Endo Pharmaceuticals ENDP announced July 11 that it no longer expects to file a new drug application for its ketoprofen pain-relief patch by the first half of 2008 because of lackluster Phase III trial results. The drug candidate failed to show statistically significant results for pain relief in ...
Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.
Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.